| In millions, except per share items | Jan-02-10 | Jan-03-09 | Dec-29-07 | Dec-30-06 | Dec-31-05 | Jan-01-05 | Dec-27-03 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | S-1/A | S-1/A |
| Revenues: |
| Non-prescription Reading Glasses | 128.5 | 126.8 | 117.9 | 95.3 | 83.2 | | |
| Sunglasses and Prescription Frames | 99.6 | 79.0 | 61.7 | 56.7 | 42.8 | | |
| International | 31.2 | 31.4 | 32.8 | 28.9 | 29.5 | | |
| Costume Jewelry | | | | 28.2 | 34.4 | | |
| Total revenues | 259.3 | 237.1 | 212.4 | 209.2 | 189.9 | 136.7 | 120.0 |
| Revenue growth [+] | 9.3% | 11.6% | 1.5% | 10.2% | 38.9% | 13.9% | |
| Non-prescription Reading Glasses | 1.4% | 7.6% | 23.6% | 14.5% | | | |
| Sunglasses and Prescription Frames | 26.1% | 28.0% | 8.8% | 32.4% | | | |
| International | -0.5% | -4.5% | 13.5% | -1.7% | | | |
| Costume Jewelry | | | | -17.9% | | | |
| Cost of goods sold | 111.9 | 104.2 | 94.1 | 104.9 | 90.6 | 74.8 | 69.3 |
| Gross profit | 147.3 | 133.0 | 118.3 | 104.3 | 99.3 | 61.9 | 50.8 |
| Gross margin | 56.8% | 56.1% | 55.7% | 49.8% | 52.3% | 45.3% | 42.3% |
| Selling, general and administrative [+] | 102.5 | 94.7 | 83.2 | 73.4 | 75.4 | 57.4 | 47.9 |
| Sales and marketing | 73.1 | 70.0 | 62.2 | 55.5 | 47.2 | 36.4 | 31.0 |
| General and administrative | 29.4 | 24.7 | 21.0 | 17.9 | 28.2 | 21.0 | 16.9 |
| Other operating expenses | 4.7 | 5.3 | 10.6 | 7.6 | 9.3 | 1.3 | |
| EBITDA [+] | 44.8 | 38.3 | 30.7 | 41.7 | 33.6 | 13.1 | 12.6 |
| EBITDA growth | 17.1% | 24.7% | -26.4% | 24.1% | 156.3% | 4.4% | |
| EBITDA margin | 17.3% | 16.2% | 14.5% | 19.9% | 17.7% | 9.6% | 10.5% |
| Depreciation | | | | 10.8 | 9.7 | 8.6 | 9.6 |
| EBITA | 44.8 | 38.3 | 30.7 | 30.9 | 23.9 | 4.5 | 2.9 |
| EBITA margin | 17.3% | 16.2% | 14.5% | 14.8% | 12.6% | 3.3% | 2.4% |
| Amortization of intangibles | 4.7 | 5.3 | 6.2 | 7.6 | 9.3 | 1.3 | |
| EBIT [+] | 40.1 | 33.0 | 24.5 | 23.3 | 14.7 | 3.2 | 2.9 |
| EBIT growth | 21.6% | 34.4% | 5.3% | 59.0% | 360.2% | 9.2% | |
| EBIT margin | 15.5% | 13.9% | 11.6% | 11.1% | 7.7% | 2.3% | 2.4% |
| Non-recurring items [+] | | | | | | 3.0 | |
| Legal settlement | | | | | | 3.0 | |
| Interest expense | 4.6 | 6.4 | 24.7 | 22.0 | 12.5 | 3.8 | 1.6 |
| Interest expense | 4.6 | 6.4 | 24.7 | 22.0 | 12.5 | 3.8 | 1.6 |
| Other income (expense), net | 0.3 | -0.1 | 0.1 | 0.2 | -0.1 | 0.0 | 2.0 |
| Pre-tax income | 35.8 | 26.5 | -0.1 | 1.5 | 2.1 | -3.6 | 3.4 |
| Income taxes | 14.2 | 9.7 | -1.9 | 4.2 | 4.0 | 3.0 | 1.0 |
| Tax rate | 39.8% | 36.7% | 3247.4% | 283.4% | 191.0% | | 29.5% |
| Minority interest | 0.8 | 1.1 | 0.7 | 0.2 | 0.4 | 0.2 | 0.1 |
| Earnings from continuing ops | 21.6 | 16.8 | 1.8 | -3.0 | -2.3 | -6.7 | 2.3 |
| Earnings from discontinued ops | -4.7 | 0.8 | 3.3 | | | | |
| Net income | 16.9 | 17.5 | 5.1 | -3.0 | -2.3 | -6.7 | 2.3 |
| Net margin | 6.5% | 7.4% | 2.4% | -1.4% | -1.2% | -4.9% | 1.9% |
| |
| Basic EPS [+] | $0.97 | $0.79 | $0.11 | ($0.20) | ($0.16) | ($0.46) | $93,536.73 |
| Growth | 23.6% | 600.0% | -156.0% | 27.1% | -65.9% | -100.0% | |
| Diluted EPS [+] | $0.96 | $0.78 | $0.11 | ($0.20) | ($0.16) | ($0.46) | $89,788.05 |
| Growth | 22.9% | 598.9% | -155.8% | 27.1% | -65.9% | -100.0% | |
| |
| Shares outstanding (basic) [+] | 22.1 | 21.3 | 15.9 | 14.8 | 14.4 | 14.5 | 0.0 |
| Growth | 3.8% | 33.7% | 7.4% | 3.2% | -0.8% | 58196014.0% | |
| Shares outstanding (diluted) [+] | 22.4 | 21.4 | 16.0 | 14.8 | 14.4 | 14.5 | 0.0 |
| Growth | 4.5% | 33.9% | 7.9% | 3.2% | -0.8% | 55863684.2% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |